Essity AB/Skr ESSITY B

1D1W1MYTD1Y5YMAX

About Essity AB

Essity AB is a global hygiene and health company headquartered in Stockholm, Sweden. The company operates in the industry of hygiene and health products, providing essentials such as tissue paper, baby diapers, feminine care products, incontinence products, and medical solutions. With a wide range of offerings segmented into Personal Care, Consumer Tissue, and Professional Hygiene, Essity serves both consumer and business markets. The company traces its origins back to the hygiene business of SCA, from which it was spun off in 2017. Essity is known for its strong market positions in Europe and significant presence in Asia, Latin America, and North America, capitalizing on a diverse brand portfolio and scale of operations to maintain competitive advantage.
Ticker
Skr ESSITY B
Sector
Consumer Essentials
Primary listing
XSTO
Employees
36,000
Headquarters
Stockholm, Sweden
Website
www.essity.com

Essity AB Metrics

BasicAdvanced
kr 174B
14.48
kr 17.73
0.37
kr 8.75
3.41%

What the Analysts think about Essity AB

Analyst ratings (Buy, Hold, Sell) for Essity AB stock.
Analyst projections of the future price of Essity AB stock.

Bulls say / Bears say

Essity is seeing volume-led growth in three of its four business areas. In Q2, Health & Medical, Personal Care and Professional Hygiene all grew, with particularly strong performance in incontinence, feminine care and medical solutions. (Essity, Essity)
The cost-saving programme is beginning to support earnings. Essity says Q2 adjusted EBITA was broadly stable year on year despite cost inflation, while savings in goods, selling and administration costs are expected to build through the second half. (Essity, StockAnalysis)
The North American feminine-care acquisition gives Essity a stronger platform in an attractive category. Management says it nearly doubles the company’s Personal Care presence in North America, while Q2 Personal Care delivered 3.8% organic growth on strong volumes and mix. (Essity, Nonwovens Industry)
Raw-material inflation is likely to squeeze margins before price increases fully reach customers. Goldman Sachs expects Q3 pricing to lag high-single-digit unit-cost inflation, while Jefferies expects higher pulp costs and a clear earnings hit in the second half. (Investing.com, MarketScreener)
Consumer Tissue remains a material weak spot. Q2 organic sales fell as both prices and volumes declined, and UBS warns that a disposal could be operationally complex because shared infrastructure may leave stranded costs and dissynergies. (Essity, Investing.com)
The turnaround is not yet broad enough to meet Essity’s growth ambitions. Q2 organic sales growth was only 0.3%, while Baby Care remained difficult and the newly acquired feminine-care business temporarily diluted Personal Care margins through integration costs. (Essity, Nonwovens Industry)
Data summarised monthly by Lightyear AI. Last updated on 17 Sept 2026.

Essity AB Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

Essity AB Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise

Funds containing Essity AB

AllEURGBPUSD
Funds
Fund name
Fund size
Skr ESSITY B weighting
iShares STOXX Europe 600 Personal & Household Goods€EXH7
€184M1.72%
iShares MSCI Europe SRI€IESE
€3.1B0.44%
iShares MSCI Europe SRI£IESG
£2.6B0.44%
iShares MSCI Europe ex-UK€IEUX
€1.5B0.14%
iShares MSCI Europe ex-UK£IEUX
£1.3B0.14%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.